Corvus Pharmaceuticals (NASDAQ: CRVS) shares more than doubled on Jan. 20 after announcing positive Phase 1…
The Nifty 50 Index remained under pressure on Tuesday as investors waited for the upcoming corporate…
Corvus Pharmaceuticals (NASDAQ: CRVS) shares more than doubled on Jan. 20 after announcing positive Phase 1…
The Indian rupee continued its strong slump against the US dollar this week, reaching a fresh…
The Nifty 50 Index remained under pressure on Tuesday as investors waited for the upcoming corporate…
The Yes Bank share price pulled back this week, despite the company publishing strong results and…
The Yes Bank share price pulled back this week, despite the company publishing strong results and…
Shell and other prominent energy groups have reportedly abandoned their six-year endeavor to establish a comprehensive…
AstraZeneca on Monday announced plans to invest $50 billion in its US operations by 2030, a…
European stock markets are set for a lower open on Tuesday, with investors remaining on edge…
From the United Kingdom to the United Arab Emirates, and from India to the United States,…
US Senator Lindsey Graham has sounded an alarm over continued oil imports from Russia by major…
